Bavarian Nordic is tackling some of the world's toughest diseases

Our Portfolio

We have a growing portfolio aimed at addressing unmet medical needs. Globally, we are focused on developing and delivering vaccines across these disease areas:


Smallpox and Ebola*

Strengthening biosecurity and global preparedness

Rabies, TBE & MPOX

Help protect every day, help protect whilst traveling


TBE, tick-borne encephalitis.
*in collaboration with Janssen


Our History

Bavarian Nordic was founded in 1994, with a vision to help improve and save lives through the development and manufacturing of innovative life-saving vaccine technologies.


Some of Our Key Milestones…

about us

Whilst proud of our achievements in vaccine development over the past 25 years, we are focused on the future. Right now, we are working on bringing patients around the globe an even greater degree of protection from infectious diseases.


Our Vision For Infectious Diseases

We aspire to help save lives by unlocking the power of the immune system. Our focus is always on the patient which is why we continue to provide prescribers and healthcare professionals with support for medical and disease education to help improve awareness. This portal for healthcare professionals will offer the latest product information, resources, learning modules and content from infectious disease specialists around the globe.

With our recent acquisition of well-known and trusted vaccine products from GSK, we are committed to delivering trusted, transparent and reliable vaccine supply. 


Our Commitment to the Prevention of Infectious Diseases


Focus on COVID-19

We initiated a Phase 2 clinical trial of our next generation COVID-19 booster vaccine using capsid virus like particle (cVLP) technology. We are also preparing to conduct a Phase III trial of the vaccine in 2022.

Providing Exceptional Customer Service

To better serve the needs of healthcare professionals globally, Bavarian Nordic has affiliate offices in Germany, USA, Switzerland and the Nordics.

Vaccine Supply

Bavarian Nordic has a state-of-the-art manufacturing plant in Denmark to ensure reliable and sustainable vaccine supply. A US-based commercial team was established in 2020 to support distribution of our rabies vaccine in the US.

Patient Education

We have an educational website intended to raise awareness and provide educational information, such as prevention measures for rabies, and other infectious diseases.